Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.88 +0.68%   SPY: 135.49 +0.22%
Quote Spy OPXA NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Opexa Therapeutics (OPXA)

@ 1:36 PM
Click the portfolio to add OPXA:
Close [X]
+ Add OPXA to Portfolio
  
  Last Trade: $0.96 -0.04 (-3.52%)
  Volume: 48,945 110% of avg daily volume
       
  Avg Volume: 51,377
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 0.96 - 0.99
  Open: 0.99
  Previous Close: 1.00
  52-wk Range: 0.89 - 2.30
  Market Cap: 21.4M
  P/E: -4.3
  Div Yield: $0.00 (0.00%)
Indexes
Stem Cell Stocks (+1.5%)
Spy OPXA

? Pro holders
? Member holders
? Items submitted
Additional OPXA resources



Customize Links
To see which Pros and tickerspy members own OPXA Sign up now
Latest OPXA Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

24/7 Wall St. Closing Bell
HUM  WMS  HON  XIDE  FTEK  ALU  AZN  OPXA  PAA  AIXG  TRGT  RJET  PKT  [MSSR]  JRCC  DYN  IRDM  SZYM  
Linked by 24/7 Wall St. - November 08, 04:07PM from (247wallst.com)
Equities started the day with a solid move up, but lost momentum after about half an hour. The downward move lasted into  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Opexa Therapeutics Reports Third Quarter 2010 Financial Results
OPXA  
Linked by GlobeNewswire - November 09, 08:30AM from (www.globenewswire.com)
THE WOODLANDS, Texas, Nov. 9, 2010 (GLOBE NEWSWIRE) -- Opexa Therapeutics, Inc. (Nasdaq:OPXA), a leading cell therapy company  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Did Dendreon Open Doors For Opexa Partnerships?
NBS  BTX  GERN  OPXA  DNDN  NVS  CUR  OSIR  
Linked by tickerspy Newswire - September 13, 02:10PM from (www.tickerspy.com)
Micro-cap stem cell research firm Opexa Therapeutics (OPXA) surged higher by 70% on Monday, ahead of the firm's presentation  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Stem Cell Shares Pop On Government Action
STEM  GERN  OPXA  CYTX  PSTI  
Linked by tickerspy Newswire - September 09, 12:34PM from (www.tickerspy.com)
Recent legal disputes have put the stem cell sector in focus after District Judge Royce Lamberth hit the brakes on an executive  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Investors Eye Stem Cell Shares Amid Court Dispute
GERN  ASTM  OPXA  CYTX  OSIR  ATHX  
Linked by tickerspy Newswire - August 26, 09:15AM from (www.tickerspy.com)
Earlier this week, U.S. District Judge Royce Lamberth hit the brakes an executive order aimed to remove "barriers to responsible  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Opexa Therapeutics Reports Second Quarter 2010 Financial Results
OPXA  
Linked by BusinessWire - August 06, 04:05PM from (www.businesswire.com)
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS),  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Opexa Reconstitutes Scientific Advisory Board with Industry Leaders
OPXA  
Linked by BusinessWire - August 05, 08:30AM from (www.businesswire.com)
Opexa Therapeutics, Inc. (NASDAQ: OPXA), a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS),  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Breaking Down Thursday’s Worst Sectors
ALY  VECO  GERN  ASTM  HEVV  OPXA  CPX  
Linked by tickerspy Newswire - July 15, 02:57PM from (www.tickerspy.com)
Stocks pared their losses after a steep morning sell off on Thursday. Disappointing manufacturing data muted strong corporate  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Two Healthcare Subsectors That Were Supposed To Rally
THC  NBS  UHS  HMA  STEM  GERN  OPXA  MDTH  SEM  CUR  
Linked by tickerspy Newswire - July 08, 03:45PM from (www.tickerspy.com)
It's been a strong month for various segments of the healthcare industry, but despite high hopes for hospitals and stem cell  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource